8,520 Shares in AdaptHealth Corp. (NASDAQ:AHCO) Acquired by Blue Trust Inc.

Blue Trust Inc. acquired a new position in AdaptHealth Corp. (NASDAQ:AHCO) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 8,520 shares of the company’s stock, valued at approximately $85,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AHCO. Vanguard Group Inc. boosted its stake in shares of AdaptHealth by 8.9% during the 1st quarter. Vanguard Group Inc. now owns 10,017,722 shares of the company’s stock valued at $115,304,000 after buying an additional 818,241 shares during the period. Reinhart Partners LLC. increased its holdings in shares of AdaptHealth by 1.4% during the 2nd quarter. Reinhart Partners LLC. now owns 4,269,303 shares of the company’s stock worth $42,693,000 after purchasing an additional 59,092 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of AdaptHealth by 21.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,040,947 shares of the company’s stock worth $7,589,000 after purchasing an additional 183,135 shares during the period. Federated Hermes Inc. increased its holdings in shares of AdaptHealth by 672.8% during the 4th quarter. Federated Hermes Inc. now owns 705,125 shares of the company’s stock worth $5,140,000 after purchasing an additional 613,882 shares during the period. Finally, First Eagle Investment Management LLC raised its stake in shares of AdaptHealth by 18.2% in the first quarter. First Eagle Investment Management LLC now owns 594,951 shares of the company’s stock worth $6,848,000 after acquiring an additional 91,772 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Trading Up 0.9 %

AHCO opened at $10.08 on Thursday. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.33 and a quick ratio of 1.11. The company has a market cap of $1.34 billion, a price-to-earnings ratio of -1.91, a price-to-earnings-growth ratio of 0.76 and a beta of 1.10. The firm has a 50 day simple moving average of $10.45 and a 200 day simple moving average of $10.00. AdaptHealth Corp. has a fifty-two week low of $6.37 and a fifty-two week high of $12.44.

AdaptHealth (NASDAQ:AHCO) last issued its earnings results on Tuesday, August 6th. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.06). AdaptHealth had a negative net margin of 21.45% and a positive return on equity of 8.47%. The firm had revenue of $805.98 million during the quarter, compared to the consensus estimate of $802.62 million. During the same period in the previous year, the company posted $0.16 EPS. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. On average, sell-side analysts anticipate that AdaptHealth Corp. will post 0.82 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on AHCO shares. Truist Financial reaffirmed a “buy” rating and issued a $13.00 target price on shares of AdaptHealth in a research note on Wednesday, May 15th. Royal Bank of Canada reissued an “outperform” rating and set a $13.00 price target on shares of AdaptHealth in a research note on Monday, August 12th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $10.70.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.